Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJun 15, 2022DuracloncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1091-2022Class IITerminatedJun 15, 2022Proventil HFAcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1090-2022Class IITerminatedJun 15, 2022Celestone SoluspancGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1089-2022Class IITerminatedJun 15, 2022Levofloxacin TabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1088-2022Class IITerminatedJun 15, 2022KinevaccGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1087-2022Class IITerminatedJun 15, 2022GastrografincGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1086-2022Class IITerminatedJun 15, 2022E-Z-Gas IIcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1085-2022Class IITerminatedJun 15, 2022E-Z-HD (Barium Sulfate for Oral Suspension)cGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1084-2022Class IITerminatedJun 15, 2022Transderm ScopcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1083-2022Class IITerminatedJun 15, 2022Recothrom Thrombin TopicalcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1082-2022Class IITerminatedJun 15, 2022RevontocGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1081-2022Class IITerminatedJun 15, 2022RevontocGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1080-2022Class IITerminatedJun 15, 2022Vecuronium Bromide for InjectioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1079-2022Class IITerminatedJun 15, 2022Propofol Injectable EmulsioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1078-2022Class IITerminatedJun 15, 2022Propofol Injectable EmulsioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1077-2022Class IITerminatedJun 15, 2022Proair, HFAcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1076-2022Class IITerminatedJun 15, 2022Mupirocin OintmentcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1075-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable Suspension USPcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1074-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable Suspension USPcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1073-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable Suspension USPcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1072-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable SuspensioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1071-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable SuspensioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1070-2022Class IITerminatedJun 15, 2022Medroxyprogesterone acetate injectable suspensioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1069-2022Class IITerminatedJun 15, 2022Lidocaine Patch 5%cGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1068-2022Class IITerminatedJun 15, 2022Levalbuterol Tartrate HFA Inhalation AerosolcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1067-2022Class IITerminatedJun 15, 2022Clonidine Hydrochloride TabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1066-2022Class IITerminatedJun 15, 2022Ketoconazole CreamcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1065-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable Suspension USPcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1064-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable SuspensioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1063-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable SuspensioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1062-2022Class IITerminatedJun 15, 2022MethyLPREDNISolone Acetate Injectable Suspension USPcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1061-2022Class IITerminatedJun 15, 2022Medroxyprogesterone acetate injectable suspensioncGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1060-2022Class IITerminatedJun 15, 2022Sulfamethoxazole and Trimethoprim TabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1059-2022Class IITerminatedJun 15, 2022Sodium Bicarbonate TabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1058-2022Class IITerminatedJun 15, 2022Promethazine HCl TabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1057-2022Class IITerminatedJun 15, 2022Metronidazole tabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1056-2022Class IITerminatedJun 15, 2022Ibuprofen Tablets USPcGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1055-2022Class IITerminatedJun 15, 2022Doxycycline Hyclate TabletscGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1054-2022Class IITerminatedJun 15, 2022Xylocaine + EpinephrinecGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1053-2022Class IITerminatedJun 15, 2022Xylocaine + EpinephrinecGMP deviations: Temperature abuseMckesson Medical-Surgical Inc. Corporate Office · D-1052-2022